2024-11-17 11:33:50
Tyvyt (Sintilimab Injection), an Innovative PD-1 Inhibitor Jointly Developed by Innovent and Lilly, is Included in the New Catalogue of National Reimbursement Drug List (NRDL)
Corporate/ 2023-07-23
Tyvyt (Sintilimab Injection), an Innovat...

SUZHOU,China,Nov. 28,2019-- Innovent Biologics,Inc. ("Innovent") (HKEX: 01801),a world-class biopharmaceutical company that develo...

Concord Medical Schedules 2019 Annual Meeting of Shareholders
Corporate/ 2023-07-23
Concord Medical Schedules 2019 Annual Me...

BEIJING,Nov. 28,2019-- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM),a spec...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release